Tower Research Capital LLC (TRC) - ACUMEN PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ACUMEN PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$8,831
-48.6%
2,128
-40.5%
0.00%
-100.0%
Q2 2023$17,196
+143200.0%
3,575
+18.3%
0.00%
Q1 2023$12
-33.3%
3,022
-7.6%
0.00%
-100.0%
Q4 2022$18
-100.0%
3,272
-59.7%
0.00%0.0%
Q3 2022$81,000
+350.0%
8,117
+108.9%
0.00%
Q2 2022$18,000
+80.0%
3,885
+52.1%
0.00%
Q1 2022$10,000
-77.3%
2,555
-60.8%
0.00%
-100.0%
Q4 2021$44,000
+340.0%
6,523
+838.6%
0.00%
Q3 2021$10,0006950.00%
Other shareholders
ACUMEN PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Sands Capital Ventures, LLC 3,417,075$14,180,8614.20%
Knollwood Investment Advisory, LLC 1,628,510$6,758,3173.16%
Altium Capital Management LP 650,000$2,697,5001.41%
RA Capital Management 14,932,063$61,968,0611.22%
GREAT POINT PARTNERS LLC 1,074,101$4,457,5190.81%
Boxer Capital, LLC 2,206,983$9,158,9790.49%
Deep Track Capital, LP 2,513,044$10,429,1330.40%
Parkman Healthcare Partners LLC 499,814$2,074,2280.38%
Rock Springs Capital Management LP 2,812,579$11,672,2030.31%
Ghost Tree Capital, LLC 150,000$622,5000.20%
View complete list of ACUMEN PHARMACEUTICALS INC shareholders